A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus
NCT05759897 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2023-03-08
Summary
The aim of this trial is to evaluate the efficacy and safety of HRS-7535 in subjects with type 2 diabetes mellitus.
Conditions
Interventions
- DRUG
-
HRS-7535
HRS-7535
- DRUG
-
Placebo
Sponsors & Collaborators
-
Shandong Suncadia Medicine Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-28
- Primary Completion
- 2023-12-21
- Completion
- 2024-01-04
More Related Trials
-
Single Escalating Dose Study Of HSK7653 In Healthy Subjects
NCT05983289 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy Subjects
NCT05152277 ·Status: COMPLETED ·Phase: PHASE1
-
the Efficacy and Safety of HRS9531 Injection in Subjects With Type 2 Diabetes， Inadequately Controlled With Diet and Exercise Alone
NCT06650007 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Relative Bioavailability Study of HRS9531 in Healthy Subjects
NCT05893576 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM
NCT06059326 ·Status: COMPLETED ·Phase: PHASE2
-
HSK7653 in Chinese Patients with Impaired Glucose Tolerance
NCT04727580 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single Injection in Healthy Subjects and Patients With Type 2 Diabetes
NCT05996380 ·Status: UNKNOWN ·Phase: PHASE1
-
Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus
NCT00532506 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects
NCT06688123 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Subcutaneous Injections of HRS9531 in Patients With Type 2 Diabetes Mellitus
NCT05516966 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of PF-06882961 in Chinese Adults With Type 2 Diabetes Mellitus
NCT04889157 ·Status: COMPLETED ·Phase: PHASE1
-
HSK7653 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
NCT04556851 ·Status: COMPLETED ·Phase: PHASE3
-
A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus
NCT03985293 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes
NCT05333835 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HMS5552 in Patients With Type 2 Diabetes
NCT02077452 ·Status: COMPLETED ·Phase: PHASE1
-
Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study
NCT01956305 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin
NCT02685345 ·Status: COMPLETED ·Phase: PHASE2
-
A HR20031 FE Study on Healthy Subjects
NCT05692934 ·Status: COMPLETED ·Phase: PHASE1
-
To Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus
NCT06481085 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone
NCT07156500 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Phase 2 Study of DS-8500a in Patients With Type 2 Diabetes
NCT02222350 ·Status: COMPLETED ·Phase: PHASE2
-
Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects
NCT05330208 ·Status: TERMINATED ·Phase: PHASE1
-
A Study of HS-20094 in Healthy Participants
NCT05116410 ·Status: UNKNOWN ·Phase: PHASE1
-
Tolerability to HS-20004 With Titration Administration in Type 2 Diabetic Patients
NCT02750007 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects.
NCT03848793 ·Status: COMPLETED ·Phase: PHASE2